articleJournal of Clinical OncologyMar 10, 2022HYBRID OA

Artificial Intelligence–Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non–Small-Cell Lung Cancer

Samsung Medical Center · Sungkyunkwan University · +5 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

PURPOSE Biomarkers on the basis of tumor-infiltrating lymphocytes (TIL) are potentially valuable in predicting the effectiveness of immune checkpoint inhibitors (ICI). However, clinical application remains challenging because of methodologic limitations and laborious process involved in spatial analysis of TIL distribution in whole-slide images (WSI). METHODS We have developed an artificial intelligence (AI)–powered WSI analyzer of TIL in the tumor microenvironment that can define three immune phenotypes (IPs): inflamed, immune-excluded, and immune-desert. These IPs were correlated with tumor response to ICI and survival in two independent cohorts of patients with advanced non–small-cell lung cancer (NSCLC).…

Citation impact

277
total citations
FWCI
26.42
Percentile
100%
References
29
Citations per year

Authors

29

Topics & keywords

Keywords
  • Immune system
  • Medicine
  • Tumor-infiltrating lymphocytes
  • Immune checkpoint
  • Lung cancer
  • Biomarker
  • Immunotherapy
  • Tumor microenvironment
No related works found for this paper.

Funding